Abbott Laboratories (ABT)

Growth

Revenue 5Y11.43%
Revenue 3Y11.77%
EPS 5Y33.24%
EPS 3Y43.58%
Dividend 5Y11.59%
Dividend 3Y17.15%

Capital Efficiency

ROIC15.88%
ROE22.01%
ROA10.84%
ROTA12.73%

Capital Structure

Market Cap192.65B
EV199.47B
Cash9.59B
Current Ratio1.86
Debt/Equity0.51
Net Debt/EBITDA0.52
Show More

Income Statement

Select a metric from the list below to chart it

Dec '85
Dec '92
Dec '99
Dec '06
Dec '13
Dec '20
Income Statement
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Revenue
21,848.0
20,247.0
20,405.0
20,853.0
27,390.0
30,578.0
31,904.0
34,608.0
43,075.0
45,030.0
Revenue % Chg.
-45.2%
-7.3%
0.8%
2.2%
31.3%
11.6%
4.3%
8.5%
24.5%
6.4%
Cost of Revenue
10,040.0
9,218.0
8,747.0
9,024.0
12,337.0
12,706.0
13,231.0
15,003.0
18,537.0
19,315.0
Cost of Revenue % Chg.
-33.6%
-8.2%
-5.1%
3.2%
36.7%
3.0%
4.1%
13.4%
23.6%
5.8%
Gross Profit
11,808.0
11,029.0
11,658.0
11,829.0
15,053.0
17,872.0
18,673.0
19,605.0
24,538.0
25,715.0
Gross Profit % Chg.
-52.3%
-6.6%
5.7%
1.5%
27.3%
18.7%
4.5%
5.0%
25.2%
6.9%
Gross Profit Margin
54.0%
54.5%
57.1%
56.7%
55.0%
58.4%
58.5%
56.6%
57.0%
57.1%
Gross Profit Margin % Chg.
-12.9%
0.8%
4.9%
-0.7%
-3.1%
6.3%
0.1%
-3.2%
0.6%
0.5%
R&D Expenses
1,452.0
1,345.0
1,405.0
1,422.0
2,235.0
2,300.0
2,440.0
2,420.0
2,742.0
2,925.0
R&D Expenses % Chg.
-66.4%
-7.4%
4.5%
1.2%
57.2%
2.9%
6.1%
-0.8%
13.3%
9.2%
Selling, General, & Admin Expenses
6,936.0
6,530.0
6,785.0
6,672.0
9,117.0
9,744.0
9,765.0
9,696.0
11,324.0
11,323.0
Selling, General, & Admin Expenses % Chg.
-42.5%
-5.9%
3.9%
-1.7%
36.6%
6.9%
0.2%
-0.7%
16.8%
4.4%
Other Expenses
791.0
555.0
601.0
550.0
1,975.0
2,178.0
1,936.0
2,132.0
2,047.0
2,031.0
Other Expenses % Chg.
-
-29.8%
8.3%
-8.5%
259.1%
10.3%
-11.1%
10.1%
-4.0%
-0.5%
Operating Income
2,629.0
2,599.0
2,867.0
3,185.0
1,726.0
3,650.0
4,532.0
5,357.0
8,425.0
9,436.0
Operating Income % Chg.
-67.5%
-1.1%
10.3%
11.1%
-45.8%
111.5%
24.2%
18.2%
57.3%
11.3%
Operating Income Margin
12.0%
12.8%
14.1%
15.3%
6.3%
11.9%
14.2%
15.5%
19.6%
21.0%
Operating Income Margin % Chg.
-40.7%
6.7%
9.5%
8.7%
-58.7%
89.4%
19.0%
9.0%
26.4%
4.6%
Total Other Income/Expenses Net
-108.0
-81.0
316.0
-1,772.0
505.0
-777.0
-455.0
-389.0
-214.0
-123.0
Total Other Income/Expenses Net % Chg.
94.1%
25.0%
-
-
-
-
41.4%
14.5%
45.0%
40.6%
Income Before Tax
2,521.0
2,518.0
3,183.0
1,413.0
2,231.0
2,873.0
4,077.0
4,968.0
8,211.0
9,313.0
Income Before Tax % Chg.
-59.7%
-0.1%
26.4%
-55.6%
57.9%
28.8%
41.9%
21.9%
65.3%
12.6%
Income Before Tax Margin
11.5%
12.4%
15.6%
6.8%
8.1%
9.4%
12.8%
14.4%
19.1%
20.7%
Income Before Tax Margin % Chg.
-26.5%
7.8%
25.4%
-56.6%
20.2%
15.4%
36.0%
12.3%
32.8%
5.8%
Income Tax Expense
138.0
797.0
577.0
350.0
1,878.0
539.0
390.0
497.0
1,140.0
1,424.0
Income Tax Expense % Chg.
-54.0%
477.5%
-27.6%
-39.3%
436.6%
-71.3%
-27.6%
27.4%
129.4%
38.0%
Net Income
2,576.0
2,284.0
4,423.0
1,400.0
477.0
2,368.0
3,687.0
4,495.0
7,071.0
7,889.0
Net Income % Chg.
-56.8%
-11.3%
93.7%
-68.3%
-65.9%
396.4%
55.7%
21.9%
57.3%
8.9%
Net Income Margin
11.8%
11.3%
21.7%
6.7%
1.7%
7.7%
11.6%
13.0%
16.4%
17.5%
Net Income Margin % Chg.
-21.2%
-4.3%
92.2%
-69.0%
-74.1%
344.7%
49.2%
12.4%
26.4%
2.3%
Weighted Avg. Shares Out
1,548.1
1,508.0
1,472.7
1,472.9
1,743.6
1,755.6
1,762.5
1,771.2
1,771.2
1,628.5
Weighted Avg. Shares Out % Chg.
-1.8%
-2.6%
-2.3%
0.0%
18.4%
0.7%
0.4%
0.5%
-
-8.1%
EPS
1.7
1.5
3.0
1.0
0.3
1.3
2.1
2.5
4.0
4.8
EPS % Chg.
-56.0%
-9.0%
98.3%
-68.4%
-71.2%
393.0%
55.1%
21.3%
57.2%
18.1%
Weighted Avg. Shares Out Dil
1,574.0
1,527.0
1,506.0
1,483.0
1,749.0
1,770.0
1,781.0
1,786.0
1,786.0
1,771.5
Weighted Avg. Shares Out Dil % Chg.
-1.1%
-3.0%
-1.4%
-1.5%
17.9%
1.2%
0.6%
0.3%
-
-1.1%
EPS Diluted
1.6
1.5
2.9
0.9
0.3
1.3
2.1
2.5
4.0
4.4
EPS Diluted % Chg.
-56.5%
-8.0%
96.0%
-67.8%
-71.3%
392.6%
54.9%
21.4%
58.4%
9.9%
Interest Income
67.0
77.0
105.0
99.0
124.0
105.0
94.0
46.0
43.0
106.0
Interest Income % Chg.
-15.4%
14.9%
36.4%
-5.7%
25.3%
-15.3%
-10.5%
-51.1%
-6.5%
158.5%
Interest Expense
157.0
150.0
163.0
431.0
904.0
826.0
670.0
546.0
533.0
535.0
Interest Expense % Chg.
-73.5%
-4.5%
8.7%
164.4%
109.7%
-8.6%
-18.9%
-18.5%
-2.4%
-0.6%
EBIT
2,431.0
2,445.0
3,125.0
1,081.0
1,451.0
2,152.0
3,501.0
4,468.0
7,721.0
8,884.0
EBIT % Chg.
-57.7%
0.6%
27.8%
-65.4%
34.2%
48.3%
62.7%
27.6%
72.8%
14.3%
EBIT Margin
11.1%
12.1%
15.3%
5.2%
5.3%
7.0%
11.0%
12.9%
17.9%
19.7%
EBIT Margin % Chg.
-22.8%
8.5%
26.8%
-66.2%
2.2%
32.8%
55.9%
17.6%
38.8%
7.4%
Depreciation & Amortization
1,719.0
1,548.0
1,472.0
1,353.0
3,021.0
3,278.0
3,014.0
3,327.0
3,538.0
3,343.0
Depreciation & Amortization % Chg.
-38.2%
-9.9%
-4.9%
-8.1%
123.3%
8.5%
-8.1%
10.4%
6.3%
-5.1%
EBITDA
4,150.0
3,993.0
4,597.0
2,434.0
4,472.0
5,430.0
6,515.0
7,795.0
11,259.0
12,227.0
EBITDA % Chg.
-51.4%
-3.8%
15.1%
-47.1%
83.7%
21.4%
20.0%
19.6%
44.4%
8.2%
EBITDA Margin
19.0%
19.7%
22.5%
11.7%
16.3%
17.8%
20.4%
22.5%
26.1%
27.2%
EBITDA Margin % Chg.
-11.2%
3.8%
14.2%
-48.2%
39.9%
8.8%
15.0%
10.3%
16.0%
1.7%